SEC Filing Update: #CRNX Crinetics Pharmaceuticals, Inc. : $84.45

Sector: Healthcare | YTD: 🔼+ 80.80% The SEC disclosed Today (13-AUG-2026) that WELLINGTON MANAGEMENT GROUP LLP has DECREASED #CRNX Shares by -12.58% 🔴 * Previous Holdings: 8.16M Shares * Current Holdings: 7.13M Shares * Decrease -1.03M * Decreased (%)-12.58% * Ownership: 6.8% https://www.thinksabio.com/reports/isr/CRNX Institutional ownership in #CRNX has been steadily rising over the past 12 quarters in Shares: Q4 2023: 70.66M Q1 2024: 80.41M Q2 2024: 82.47M Q3 2024: 84.51M Q4 2024: 99.68M Q1 2025: 101.90M Q2 2025: 104.56M Q3 2025: 107.71M Q4 2025: 111.61M Q1 2026: 122.74M The quarterly average prices of #CRNX: Q3 2025: $31.98 Q4 2025: $44.47 Q1 2026: $44.65 📌 Institutional activity in the last 30 days for #CRNX: • FARALLON CAPITAL MANAGEMENT LLC – Increased holdings by 651,000 shares (03-AUG-2026)